Korea S.E.
06/12/2024
5-day change
1st Jan Change
3,790.00 KRW
-1.43%
-4.17%
-2.19%
Kang Stem Biotech Co., Ltd. announced that it has received KRW 47.99962221 billion in funding from a group of investors
On July 11, 2019, Kang Stem Biotech Co., Ltd. (KOSDAQ:A217730) closed the transaction. The transaction included participation from new investor E&Investment, Inc..
LS SECURITIES Co., Ltd. agreed to acquire 34.05% stake in REFINE Co., Ltd. from Lee Chang Seop, Lee Gil Jae, Kim Wan Tae, Hwang Se Eun, Park Byung Yang, Hwang Yun Seok and others for approximately KRW 160 billion.
12-02
CI
S.Biomedics Co., Ltd. announced that it has received KRW 10.8 billion in funding from a group of investors
11-12
CI
Nongshim Co., Ltd. announced that it has received KRW 138.4587685 billion in funding from a group of investors
09-02
CI
LS SECURITIES Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
08-14
CI
Seojin System Co.,Ltd announced that it expects to receive KRW 100 billion in funding from a group of investors
08-01
CI
Curiox Biosystems Co., Ltd announced that it has received KRW 20 billion in funding from KB Securities Co.,Ltd, LS SECURITIES Co., Ltd., JB Woori Capital Co., Ltd, Kiwoom Securities Co., Ltd., KDB Capital Corp., IBK Capital Corporation and other investors
07-25
CI
Curiox Biosystems Co., Ltd announced that it expects to receive KRW 20 billion in funding from KB Securities Co.,Ltd, LS SECURITIES Co., Ltd., JB Woori Capital Co., Ltd, Kiwoom Securities Co., Ltd., KDB Capital Corp., IBK Capital Corporation and other investors
07-22
CI
Kmw Inc. announced that it has received KRW 30 billion in funding from a group of investors
07-07
CI
Kmw Inc. announced that it expects to receive KRW 30 billion in funding from a group of investors
07-03
CI
Chabiotech Co.,Ltd. announced that it has received KRW 74.799682128 billion in funding from a group of investors
05-15
CI
LS SECURITIES Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-14
CI
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors
05-08
CI
Chabiotech Co.,Ltd. announced that it expects to receive KRW 74.799682128 billion in funding from a group of investors
05-07
CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors
05-06
CI
Amosense Co.,Ltd. announced that it has received KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.
04-25
CI
Amosense Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd.
04-23
CI
LS SECURITIES Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
03-21
CI
SIMMTECH Co., Ltd. announced that it has received KRW 100 billion in funding from a group of investors
03-11
CI
SIMMTECH Co., Ltd. announced that it expects to receive KRW 100 billion in funding from a group of investors
03-07
CI
KOREA PHARMA Co., Ltd. announced that it has received KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd.
11-27
CI
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd. and others
11-23
CI
Cha Vaccine Research Institute Co., Ltd. announced that it has received KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
11-16
CI
Cha Vaccine Research Institute Co., Ltd. announced that it expects to receive KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.
11-14
CI
LS SECURITIES Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-14
CI
Foodnamoo., Inc. announced that it has received KRW 8 billion in funding from Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., KB Securities Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd.
11-09
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
A078020: Dynamic Chart
LS Securities Co Ltd, formerly EBest Investment & Securities Co Ltd, is a Korea-based company principally engaged in the financial investment and securities services provision business. The Company mainly provides securities investment brokerage services such as equity securities, debt securities, investment securities, investment contract securities, derivatives-linked securities and foreign currency securities, consignment trading services such as real-time ordering, quoting and securities information inquiring for stock futures, options and funds, as well as own trading services. The Company also provides underwriting, arranging and lending services.
More about the company
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
LS SECURITIES CO., LTD. 
